Laboratorio Reig Jofre SA
MAD:RJF
Laboratorio Reig Jofre SA
MAD:RJF
Price:
2.48
EUR
1.22%
Market Closed
Market Cap:
€203.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Laboratorio Reig Jofre SA
MAD:RJF
|
ES |
|
G
|
Great Southern Copper PLC
LSE:GSCU
|
UK |
|
W
|
Walt Disney Co
SGO:DIS
|
US |
|
A
|
American Express Co
XMUN:AEC1
|
US |
|
GYM Group PLC
LSE:GYM
|
UK |
|
Z
|
Zalando SE
WSE:ZAL
|
DE |
|
Companhia de Saneamento Basico do Estado de Sao Paulo SABESP
NYSE:SBS
|
BR |
|
Emmerson PLC
LSE:EML
|
IM |
|
Hyundai Home Shopping Network Corp
KRX:057050
|
KR |
|
Qorvo Inc
NASDAQ:QRVO
|
US |
|
V
|
Vincit Oyj
OMXH:VINCIT
|
FI |
|
P
|
Pmc Fincorp Ltd
BSE:534060
|
IN |
Multiples-Based Value
The Multiples-Based Value of one
RJF
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 2.48 EUR,
Laboratorio Reig Jofre SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RJF Multiples-Based Value
LOCKED
Multiples Across Competitors
RJF Competitors Multiples
Laboratorio Reig Jofre SA Competitors
Laboratorio Reig Jofre SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Laboratorio Reig Jofre SA
MAD:RJF
|
201.9m EUR | 0.6 | 40.2 | 7.9 | 40.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
